SEC EDGARSEP 11 min read$LRCX

Harter Ava sold $1.5M of LRCX

Harter Ava (Chief Legal Officer) sold 5,000 shares of LAM RESEARCH CORP (LRCX) at $302.46 ($1.51M total) on 2026-08-31 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · Harter Ava

Published Sep 1, 2026, 4:08 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 1, 2026, 4:33 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$LRCX

Bearish

medium confidence

Mentioned

$LRCX

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$LRCXBearishLow

Why it matters

The sale reduces insider ownership but does not alter LRCX's fundamentals; traders may watch for follow‑on insider activity.

Market read

Primary insider sale of a senior officer; modest short‑term trading relevance.

What to watch

Potential upcoming legal matters or compensation restructuring not disclosed could be driving the sale.

Relevance 5/10Novelty 7/10Timing: post‑market filing on Sep 1, 2026

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the sale.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$LRCXBearishMedium confidence

Context

Chief Legal Officer Harter Ava sold 5,000 LRCX shares for $1.5M via a 10b5-1 plan, reducing her stake to 42,462 shares.

Expected impact

Potential modest downside pressure of 1‑2% over the next few days.

Evidence & confidence

A $1.5M sale by a C‑level insider is material but not unusual; market reaction typically modest unless accompanied by other news.

Market effects

Sector

Minor impact on semiconductor equipment sector; no broader sector shift expected.

Regional

U.S. market only; no regional ripple.

Global

Limited to investors tracking LRCX insider activity.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to company outlook; price may remain stable.

Key entities

Company
LAM Research Corp
Semiconductor equipment manufacturer (ticker LRCX).
Person
Harter Ava
Chief Legal Officer of LAM Research.

Read at source ← All news

OCT 13

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

tradingview.com2 min

OCT 13

$AMATMed

Applied Materials shares slide as chip equipment outlook remains uncertain

Applied Materials (AMAT) shares dropped 7.5% after it declined to provide a wafer fabrication equipment (WFE) spending forecast, citing uncertainties. CEO Gary Dickerson expressed long-term confidence in AI-driven demand but highlighted near-term variables. Semiconductor equipment peers KLA Corp., Lam Research, and ASML Holding also fell. ASML's upcoming earnings are in focus.

investing.com4 min

OCT 9

$LRCXHigh

Wells Fargo Adjusts Price Target on Lam Research to $355 From $350

Wells Fargo raised its price target for Lam Research (LRCX) to $355 from $350. Morgan Stanley also adjusted its target to $385 from $367, maintaining an overweight rating. LRCX shares closed at $320.59, down 2.71%.

marketscreener.com1 min

OCT 9

$LRCXLow

Round Design Infringement Case Against Lam Research < Supply Chain < 기사본문

BCNC, a South Korean semiconductor component maker, was ordered by a Seoul court to stop producing and distributing certain edge-ring products, pay damages, and destroy existing inventory, following a design-right infringement lawsuit by Lam Research. The court partially dismissed Lam Research's claims. Both companies are also involved in separate patent disputes, with mixed rulings. BCNC plans to appeal the decision.

thelec.net2 min

OCT 8

$LRCXMedAI 8/10

Lam Research Stocks Fall 2.1% as AI Spending Lifts Target 33%

Lam Research (LRCX) shares fell 2.42% to $325.81 on October 7, despite Cantor Fitzgerald raising its price target to $425 from $320. The company reported June-quarter revenue of $6.72 billion, up 15.1% from the prior quarter, with improved margins. Cantor's target suggests 30.4% upside, but shares are 106.68% above GF Value™ estimate of $157.64.

gurufocus.com2 min

OCT 6